Eric A. Hughes - 11 Dec 2024 Form 4 Insider Report for Monte Rosa Therapeutics, Inc. (GLUE)

Role
Director
Signature
/s/ Markus Warmuth, Attorney-in-Fact
Issuer symbol
GLUE
Transactions as of
11 Dec 2024
Net transactions value
$0
Form type
4
Filing time
13 Dec 2024, 09:05:04 UTC
Previous filing
13 Aug 2024
Next filing
05 Mar 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GLUE Stock Option (Right to Buy) Award $0 +44,200 $0.000000 44,200 11 Dec 2024 Common Stock 44,200 $8.51 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest and become exercisable in 36 substantially equal monthly installments following the grant date, subject to the Reporting Person's continued service on each such vesting date.